Journal of Cystic Fibrosis
Volume 9, Issue 4 , Pages 288-291 , July 2010

Cystic fibrosis gene mutations and gastrointestinal diseases

  • Shahram Bahmanyar

      Affiliations

    • Clinical Epidemiology Unit, Department of Medicine, Karolinska Hospital, Stockholm, Sweden
    • Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
    • Corresponding Author InformationCorresponding author. Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Karolinska Hospital, SE-171 76 Stockholm, Sweden. Tel.: +46 8 517 79323; fax: +46 8 517 79304.
    • ,
  • Anders Ekbom

      Affiliations

    • Clinical Epidemiology Unit, Department of Medicine, Karolinska Hospital, Stockholm, Sweden
    • ,
  • Johan Askling

      Affiliations

    • Clinical Epidemiology Unit, Department of Medicine, Karolinska Hospital, Stockholm, Sweden
    • ,
  • Marie Johannesson

      Affiliations

    • Department, Paediatrics and Child Health, University of Otago, Wellington, New Zealand
    • ,
  • Scott M. Montgomery

      Affiliations

    • Clinical Epidemiology Unit, Department of Medicine, Karolinska Hospital, Stockholm, Sweden
    • Clinical Epidemiology and Biostatistics Unit, Örebro University Hospital, Örebro, Sweden
    • Department of Primary Care and Social Medicine, Charing Cross Hospital, Imperial College, London, UK

Received 9 February 2010 ,Revised 24 March 2010 ,Accepted 25 March 2010.

References 

  1. Bobadilla JL, Macek M, Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations—correlation with incidence data and application to screening. Hum Mutat. 2002;19:575–606
  2. Romero IG, Ober C. CFTR mutations and reproductive outcomes in a population isolate. Hum Genet. 2008;122:583–588
  3. Gabriel SE, Brigman KN, Koller BH, Boucher RC, Stutts MJ. Cystic-fibrosis heterozygote resistance to cholera-toxin in the cystic-fibrosis mouse model. Science. 1994;266:107–109
  4. Pier GB, Grout M, Zaidi T, Meluleni G, Mueschenborn SS, Banting G, et al. Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature. 1998;393:79–82
  5. Hogenauer C, Santa Ana CA, Porter JL, Millard M, Gelfand A, Rosenblatt RL, et al. Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: an evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion. Am J Hum Genet. 2000;67:1422–1427
  6. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet. 2002;359:14–22
  7. Macfarlane GT, Blackett KL, Nakayama T, Steed H, Macfarlane S. The gut microbiota in inflammatory bowel disease. Curr Pharm Des. 2009;15:1528–1536
  8. The Swedish Hospital Discharge Register 1987–1996 Quality and Contents. Stockholm: The National Board of Health and Welfare; 1998;
  9. Lannefors L, Lindgren A. Demographic transition of the Swedish cystic fibrosis community—results of modern care. Respir Med. 2002;96:681–685
  10. Statistics-Sweden. Bakgrundsfakta till befolknings- och välfärdsstatistik (The Multi-Generation Registry). Örebro: Statistics Sweden; 2001;
  11. Johannesson M, Askling J, Montgomery SM, Ekbom A, Bahmanyar S. Cancer risk among patients with cystic fibrosis and their first-degree relatives. Int J Cancer. 2009;125(12):2953–2956
  12. Castellani C, Quinzii C, Altieri S, Mastella G, Assael BM. A pilot survey of cystic fibrosis clinical manifestations in CFTR mutation heterozygotes. Genet Test. 2001;5:249–254
  13. Wilschanski M. Patterns of gastrointestinal disease associated with mutations of CFTR. Curr Gastroenterol Rep. 2008;10:316–323
  14. Lloyd-Still JD. Crohn's disease and cystic fibrosis. Dig Dis Sci. 1994;39:880–885
  15. Wilschanski M, Rivlin J, Cohen S, Augarten A, Blau H, Aviram M, et al. Clinical and genetic risk factors for cystic fibrosis-related liver disease. Pediatrics. 1999;103:52–57
  16. McCarthy VP, Mischler EH, Hubbard VS, Chernick MS, di Sant'Agnese PA. Appendiceal abscess in cystic fibrosis. A diagnostic challenge. Gastroenterology. 1984;86:564–568
  17. Shields MD, Levison H, Reisman JJ, Durie PR, Canny GJ. Appendicitis in cystic fibrosis. Arch Dis Child. 1991;66:307–310
  18. Socialstyrelsen. [cited 2009 12 AUGUST]; Available from: http://www.socialstyrelsen.se/NR/rdonlyres/BCCD170B-E998-411B-8F6A-40A2E6A3890D/0/Kvalitetochinnehall19642004.pdf.

PII: S1569-1993(10)00037-8

doi: 10.1016/j.jcf.2010.03.010

Journal of Cystic Fibrosis
Volume 9, Issue 4 , Pages 288-291 , July 2010

Article Tools